Scholar Rock prepares apitegromab launch as FDA decision expected by September 30, 2026
AI Summary- Scholar Rock is preparing to launch apitegromab for spinal muscular atrophy.
- FDA approval is expected by September 30, 2026.
- Manufacturing delays were attributed to production issues, not drug safety.